Alumis (ALMS) Other Working Capital Changes (2023 - 2025)
Alumis (ALMS) reported Other Working Capital Changes of -$1.7 million for Q4 2025, down 360.74% year-over-year from $666174.0 in Q4 2024, and down 160.42% quarter-over-quarter from -$667000.0 in Q3 2025.
Alumis (ALMS) Other Working Capital Changes (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Other Working Capital Changes data on file, last reported at -$1.7 million in Q4 2025.
- Other Working Capital Changes for Q4 2025 came in at -$1.7 million, down 360.74% year-over-year; the trailing twelve-month figure through Dec 2025 was $207000.0 (up 111.14% YoY), and the FY2025 annual result was $207000.0, up 111.14% from the prior year.
- Other Working Capital Changes slipped to -$1.7 million in Q4 2025 per ALMS's latest filing, from -$667000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $2.6 million in Q1 2025 and troughed at -$1.7 million in Q4 2025.
- A 3-year average of -$156222.2 and a median of -$377000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes plunged 9380.0% in 2024, then soared 1482.42% in 2025.
- A 3-year view of Other Working Capital Changes shows it stood at $250000.0 in 2023, then sank by 250.8% to -$377000.0 in 2024, then plunged by 360.74% to -$1.7 million in 2025.
- Business Quant data shows ALMS's Other Working Capital Changes at -$1.7 million in Q4 2025, -$667000.0 in Q3 2025, and $2.6 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.74 Mn |
| Dec 31, 2025 | -1.74 Mn |
| Sep 30, 2025 | -667,000.00 |
| Sep 30, 2025 | -667,000.00 |
| Mar 31, 2025 | 2.61 Mn |
| Mar 31, 2025 | 2.61 Mn |
| Dec 31, 2024 | -377,000.00 |
| Dec 31, 2024 | -377,000.00 |
| Sep 30, 2024 | -474,000.00 |
| Sep 30, 2024 | -474,000.00 |
| Jun 30, 2024 | -1.17 Mn |
| Jun 30, 2024 | -1.17 Mn |
| Mar 31, 2024 | 165,000.00 |
| Mar 31, 2024 | 165,000.00 |
| Dec 31, 2023 | 250,000.00 |
| Dec 31, 2023 | 250,000.00 |
| Sep 30, 2023 | -5,000.00 |
| Sep 30, 2023 | -5,000.00 |